METABOLIC SYNDROME, NEUROINFLAMMATION AND COGNITIVE IMPAIRMENT: STATE OF LEVEL OUTPATIENT CLINIC IN ITALY

Similar documents
Diabetes Mellitus and Dementia. Andrea Shelton & Adena Zadourian

Neuroinflammation in preclinical AD: in vivo evidence

Delirium, Apo-E status, and AD CSF biomarkers

Delirium clinical and research challenges

Theme Topics Subtopics. Basic and Translational Science. Development of New Models and Analysis Methods

A Dynamic Model of Care for Late Onset Cognitive Impairment. Linda CW Lam Department of Psychiatry The Chinese University of Hong Kong

TREATING NEUROINFLAMMATION, TREATING DISEASE

ILSI Europe Satellite Workshop on Nutrition for the Ageing Brain: Towards Evidence for an Optimal Diet July 2014, Milan, Italy

The Marmoset Monkey as Model for Neurological Disorders

Vascular and Degenerative Causes of Cognitive Impairment: How are they linked?

The Primary Care Guide To Understanding The Role Of Diabetes As A Risk Factor For Cognitive Loss Or Dementia In Adults

Fact Sheet Alzheimer s disease

Statins and Cognition A Focus on Mechanisms

Thesis for doctoral degree (Ph.D.) 2007 Predictors of cognitive decline in memory clinic patients. Christin Andersson. Christin Andersson

TGF-ß1 pathway as a new pharmacological target for neuroprotection in AD. Filippo Caraci

KA Toulis, K. Dovas, M. Tsolaki. The endocrine facets of Alzheimer s disease and dementia-related disorders


Chapter 1. Introduction

CSF Aβ1-42 predicts cognitive impairment in de novo PD patients

Microglia, Inflammation, and FTD

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease

Dementia and cognitive decline

Biomarkers for Alzheimer s disease

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

Neurodegenerative disorders and diabetes: common underlying impairments. N.M. Lalic (Serbia)

The Role of the Immune System in Translating Early-Life Experience to Later-Life Brain and Behavior

Mild Cognitive Impairment

The role of the vascular system in dementia

Oral health status and Cognitive impairment

Tumour Necrosis Factor Modulation for Treatment of Alzheimer s Disease

FRAGILITÀ, DISABILITÀ E MALATTIE NELLO STUDIO PRO.V.A. Enzo Manzato (Padova)

Toxicity of Inorganic Copper from Drinking Water in the Causation of Alzheimer s Disease

Metabolic Syndrome: Bad for the Heart and Bad for the Brain? Kristine Yaffe, MD Univ. of California, San Francisco

Inflammation in dementia

USE OF BIOMARKERS TO DISTINGUISH SUBTYPES OF DEMENTIA. SGEC Webinar Handouts 1/18/2013

Alzheimer s disease: the state of play

Alzheimer s Disease without Dementia

28/04/51. Introduction. Insulin signaling effects on memory and mood. Is accelerated brain aging a consequence of diabetes? chronic hyperglycemia

Disentangling Delirium and Dementia

Dementia and Healthy Ageing : is the pathology any different?

8/14/2018. The Evolving Concept of Alzheimer s Disease. Epochs of AD Research. Diagnostic schemes have evolved with the research

Positron Emission Tomography of Translocator Protein 18 kda (TSPO) as a Biomarker of Neuroinflammation in Dementia and in Depression

NUTRITION & IMMUNITY IN OLDER AGE

HOW NUTRITION CHANGES THE AGING BRAIN. Nafisa Jadavji, PhD

The Impact of Type 2 Diabetes on Cognition

Is Alzheimer s Disease Type 3 Diabetes?

Understanding Symptoms, Causes, and Risks for Alzheimer s Disease

Objective 4/22/2019. Interaction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation.

Interaction of Cardiovascular Disease and Alzheimer s Disease: Implications for Cardiopulmonary Rehabilitation

Neuroprotective properties of GLP-1 - a brief overview. Michael Gejl Jensen, MD Dept. Of Pharmacology, AU

Central nervous system

Dementia. Jeanette Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine

For personal use only. Annual General Meeting 13 November 2015

Depression, omega 3 fatty acid therapy 13

Mild Cognitive Impairment (MCI)

Flicker Light-Induced Retinal Vasodilation is Lower in Alzheimer s Disease

4.1 Executive summary. Our mission and goals. Systems Neurology: We define systems neurology as a new research field where systems biology and

Be a part of the solution.

Microglia preconditioning (priming) in central nervous system pathologies

Bee venom acupuncture in different neurological illness and its immune modulation ACKNOWLEDGMENTS

INTRODUCTION TO NEUROLOGICAL DISEASE Learning in Retirement Session #6 Alzheimer disease

Plasma Phospholipids Identify Antecedent Memory Impairment in Older Adults. Madeline Haff, Bikem Sonmezler, & Rosie Chu

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018

How can the new diagnostic criteria improve patient selection for DM therapy trials

Infiltrative Brain Mass Due To Progressive Alzheimer's Disease

The role of geriatricians in management of dementia - from the viewpoint of life style modification -

RESEARCH AND PRACTICE IN ALZHEIMER S DISEASE VOL 10 EADC OVERVIEW B. VELLAS & E. REYNISH

From Gums to Guts: Periodontal Medicine KEY SLIDES. UCSF Osher Mini-Medical School October 15, /8/2015. environmental factors (smoking)

MEDICAL LIFESTYLE INTERVENTIONS FOR BRAIN HEALTH

Anxiety, Depression, and Dementia/Alzheimer Disease: What are the Links?

Practical Matters in the Care of A Person with Dementia

Prevention, health promotion & early intervention in dementia

Moving Targets: An Update on Diagnosing Dementia in the Clinic

The good things in life: can coffee consumption reduce the risk of developing Alzheimer s Disease?

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky

The Impact of Ageing & Dementia for People with Down Syndrome. Evelyn Reilly Clinical Nurse Specialist Dementia

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

UvA-DARE (Digital Academic Repository) Vascular factors in dementia and apathy Eurelings, Lisa. Link to publication

Postoperative Delirium and Sleep Apnea

Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD

Overview of neurological changes in Alzheimer s disease. Eric Karran

The neuroinflammatory hypothesis of delirium

Advances in Alzheimer s diagnosis; implications for clinical practice. Wiesje M. van der Flier Alzheimer Europe Conference Berlin, 4 October 2017

Il processo diagnostico dell Alzheimer dalla clinica al neuroimaging Giovanni B. Frisoni M.D.

TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019

Outline. Facts and figures Action plans Early / correct diagnosis Conclusions

Nutrients and Circulatory Function

Neuropsychiatric symptoms as predictors of MCI and dementia: Epidemiologic evidence

The Aging Brain The Aging Brain

Oscar L. Lopez, M.D. Departments of Neurology and Psychiatry Alzheimer s Disease Research Center University of Pittsburgh School of Medicine

Chapter 4. Cognitive decline precedes late-life longitudinal changes in vascular risk factors

Herpes Simplex Virus Type 1 and Alzheimer s disease:

Stem Cells and the Study of Neurodegeneration. Tracy Young-Pearse, PhD September 12, 2014!

Exploring the Reno-Cardiac Connection. Protect your kidneys save your heart

Mechanisms of Autontibodies

Chronic Conditions The need for a comprehensive public health approach

OBESITY IN PRIMARY CARE

Cognitive Reserve In Alzheimer s Disease: Implications for Detection and Prevention

Transcription:

METABOLIC SYNDROME, NEUROINFLAMMATION AND COGNITIVE IMPAIRMENT: STATE OF THE ART AND DATA FROM A SECOND LEVEL OUTPATIENT CLINIC IN ITALY Valeria Calsolaro Post graduating school on Geriatric medicine University of Pisa Italy

ALZHEIMER S DISEASE 35.6 million people worldwide living with dementia in 2010, expected to become 65.7 million in 2030 and 115.4 million in 2050 Alzheimer s disease (AD) is the most prevalent type of dementia, comprising about 60% 70% of all dementia cases

AMYLOID CASCADE HYPOTHESIS NOT ENOUGH

authoptic and imaging studies showed that amyloid deposition, such as neurofibrillarytangles,can be found in cognitively and well-educated normal old subjects therapeutics attempt to clear Aβ, although efficient in reducing Aβload both in animal and human models, didn t stop or reduce the progression of AD

NEUROINFLAMMATION INFLAMMATORY RESPONSE IN THE CENTRAL NERVOUS SYSTEM, DUE TO INJURY; ASTROCITES AND MICROGLIAL CELLS ARE THE MAIN ACTORS IN THE INFLAMMATORY RESPONSE IN THE CNS Modiefied from Microglia function in Alzheimer s disease Egle Solito1 and Magdalena Sastre

SELF-PERPETUATING CYCLE OF NEURONAL DAMAGE/DEATH FOLLOWED BY MICROGLIAL ACTIVATION IS COMMONLY REFERRED TO AS REACTIVE MICROGLIOSIS AND MAY BE AN UNDERLYING MECHANISM OF THE PROGRESSIVE NATURE OF DIVERSE NEURODEGENERATIVE DISEASES, INCLUDING ALZHEIMER'S DISEASE... NADPH oxidase as a therapeutic target in Alzheimer's disease. Michelle L Block

NEUROINFLAMMATION AND NEURODEGENERATION: SUPPORTING EVIDENCE up-regulated inflammatory mechanisms co-localize in the same region with high level of AD pathology, absent in the region with low AD susceptibility (eg cerebellum) microscopicalexaminations showed that inflammatory mediators are expressed overall closest to the Aβdeposits and neurofibrillary tangles http://ucmkitazawa.web.fc2.com/mind_project.html

NEUROINFLAMMATION AND NEURODEGENERATION: SUPPORTING EVIDENCE subjects withouthdementia but authopticfunding of limbic Aβand neurofibrillarytangles sufficient to pone diagnosis of AD show a modest elevation of inflammatory markers, greater than non dement subjects but less than AD subjects ultrastructural evidence of inflammatory toxicity in AD brain potential protective effect of the chronic use of Non-Steroidal Anti- Inflammatories

PERIPHERIC INFLAMMATION AND NEUROINFLAMMATION inflammatory mediators by cells local to the insult liver acute phase response and immune cell recruitment from the bone marrow. The circulating cytokines also communicate with brain centres through the cerebral endothelium, the vagal nerve and the circumventricular organs to effect local cytokine and prostaglandin synthesis and produce sickness behaviours such as fever and reduced locomotor activity. IL and TNFalpha

PERIPHERIC INFLAMMATION AND NEUROINFLAMMATION periodontitis, a clinical condition characterized by chronic periodontal inflammation and systemic release of inflammatory cytokines (Il-1, Il6, TNF)

PERIPHERIC INFLAMMATION AND NEUROINFLAMMATION METABOLIC SYNDROME:

Longitudinal cohort study, counting 1624 Latinos aged 60 and older who participated. Conclusions: Metabolic syndrome and inflammation may both contribute to cognitive decline in older people of diverse backgrounds the composite measure of metabolic syndrome is a greater risk for cognitive decline than its individual components. A 5-year prospective observational study conducted from 1997 to 2002 at community clinics at 2 sites, for a total of 2632 black and white elders (mean age, 74 years). Conclusions: metabolic syndrome contributes to cognitive impairment in elders, but primarily in those with high level of inflammation

A total of 2097 participants from a sample of 5632 65 84-year-old subjects from the Italian Longitudinal Study on Aging Among MCI patients the presence of MetSindependently predicted an increased risk of progression to dementia over 3.5 years of follow-up.

High cholesteroland systolicblood pressure were significant predictors of dementia and their risk was additive to that of obesity in this population. Midlife obesity, high SBP, and high total cholesterol level were all significant risk factors for dementia, each of them increasing the risk around 2 times. Clustering of these vascular risk factors increased the risk of dementia and AD in an additive manner so that persons with all 3 risk factors had around a 6 times higher risk for dementia than persons having no risk factors.

ALZHEIMER S OUTPATIENT CLINIC LIVORNO HOSPITAL (TUSCANY) subjects (n=127) female (n=76) male (n=51) p (F vs M) Age 78,2±7,1 78,5±7,1 77,6±7,2 0,5 MMSE 20,6±5,1 20,2±4,9 21,0±5,4 0,4 HBP 53,1% 54,2% 51,4% 0,8 DM 34,7% 35,6% 33,3% 0,6 IFG 7,9% 10,2% 4,8% 0,6 Dyslipidemia 79,1% 88,5% 64,7% 0,08 CVI 53,1% 48,8% 57,9% 0,4 CRI 24,0% 48,6% 30,9% 0,4 Inflammation indexes 41,7% 48,6% 30,4% 0,2 With contribution of Cassa di Risparmio di Livorno

ALZHEIMER S OUTPATIENT CLINIC LIVORNO HOSPITAL (TUSCANY) p=0.02 30 p=0.05 Mean MMS SE score 25 20 15 10 1 <65 n=7 2 65-75 n=28 3 75-85 n=66 4 >85 n=26 5 0 1 q. 2 q. 3 q. 4 q. Quartiles of age With contribution of Cassa di Risparmio di Livorno

ALZHEIMER S OUTPATIENT CLINIC LIVORNO HOSPITAL (TUSCANY) PREVALENCE OF CARDIOVASCULAR RISK FACTORS 50 40 Patients % 30 20 10 0 All M F All M F All M F 1 risk factor 2 risk factors 3 risk factors With contribution of Cassa di Risparmio di Livorno

INTERESTINGLY, ALTHOUGH THE ASSOCIATION BETWEEN PERIPHERAL INFLAMMATION AND COGNITIVE IMPAIRMENT IS GENERALLY RECOGNIZED, RHEUMATOID ARTHRITIS, A TYPICAL SYSTEMIC AUTOIMMUNE DISORDER, SEEMS NEGATIVELY ASSOCIATED TO ALZHEIMER S DISEASE DEVELOPMENT

On this basis, we propose a translational research project Relationship between cognitive function and inflammation in animal models and in patients with morbid obesity, rheumatoid arthritis, osteoarthritis and periodontitis to evaluate the effect of peripheral chronic inflammation on neuro-inflammation and cognitive function as well as AD pathophysiology,

GOALS: Demonstrate that peripheral chronic inflammation, depending on the cytokine pattern, specific for MORBID OBESE, REUMATHOID ARTHRITIS AND PERIODONTITIS PATIENTS, could act at CNS level and favor or prevent negative inflammation and consequent oxidative stress on the ad developing process. Pisa University Hospital: Geriatrics Unit (PI) RheumathologyUnit OdontostomatholgyUnit Neurology Unit Endocrinology Unit Imperial College, London: Neuro-Imaging Unit, Hammersmith Hospital

THANK YOU